In addition, the observation that the treatment with PE-EVOOs efficiently reduces specifically monocytic TNF-α production confirms that their use could be beneficial to RA symptoms, given its role in cartilage and bone infiltration and destruction characterizing RA progression. Here, TNF is linked to rheumatoid arthritis.